Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland Texas A&M University, College Station, Texas